Microbot Medical Inc. (MBOT)
USD 0.97
(-3.69%)
USD 0.97
(-3.69%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -9.85 Million USD | 99.93% |
| 2022 | -13.28 Million USD | -16.94% |
| 2021 | -11.35 Million USD | -24.95% |
| 2020 | -9.08 Million USD | -25.54% |
| 2019 | -7.24 Million USD | -199.94% |
| 2018 | 7.24 Million USD | 237.54% |
| 2017 | -5.26 Million USD | 45.33% |
| 2016 | -9.63 Million USD | 73.76% |
| 2015 | -36.72 Million USD | -18.8% |
| 2014 | -30.91 Million USD | -8.06% |
| 2013 | -28.6 Million USD | -26.88% |
| 2012 | -22.54 Million USD | 16.91% |
| 2011 | -27.13 Million USD | -192.42% |
| 2010 | 29.35 Million USD | -0.06% |
| 2009 | 29.37 Million USD | 9.87% |
| 2008 | 26.73 Million USD | -6.48% |
| 2007 | 28.59 Million USD | 33.79% |
| 2006 | 21.37 Million USD | 30.4% |
| 2005 | 16.38 Million USD | 6.42% |
| 2004 | 15.39 Million USD | 26.79% |
| 2003 | 12.14 Million USD | 18.96% |
| 2002 | 10.21 Million USD | -11.88% |
| 2001 | 11.58 Million USD | 25.04% |
| 2000 | 9.26 Million USD | 193.69% |
| 1999 | -9.88 Million USD | -173.26% |
| 1998 | 13.5 Million USD | 195.07% |
| 1997 | -14.2 Million USD | -190.45% |
| 1996 | 15.7 Million USD | 109.33% |
| 1995 | 7.5 Million USD | -55.62% |
| 1994 | 16.9 Million USD | 38.52% |
| 1993 | 12.2 Million USD | 25.77% |
| 1992 | 9.7 Million USD | 51.56% |
| 1991 | 6.4 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -2.51 Million USD | -5.33% |
| 2024 Q1 | -2.38 Million USD | -15.28% |
| 2023 Q1 | -2.91 Million USD | 4.86% |
| 2023 FY | -9.85 Million USD | 25.8% |
| 2023 Q4 | -2.06 Million USD | 18.71% |
| 2023 Q2 | -2.32 Million USD | 20.38% |
| 2023 Q3 | -2.54 Million USD | -9.47% |
| 2022 FY | -13.28 Million USD | -16.94% |
| 2022 Q4 | -3.06 Million USD | 11.69% |
| 2022 Q3 | -3.47 Million USD | 2.5% |
| 2022 Q2 | -3.56 Million USD | -12.19% |
| 2022 Q1 | -3.17 Million USD | 19.33% |
| 2021 FY | -11.35 Million USD | -24.95% |
| 2021 Q1 | -2.39 Million USD | 8.95% |
| 2021 Q2 | -2.47 Million USD | -3.51% |
| 2021 Q3 | -2.55 Million USD | -3.07% |
| 2021 Q4 | -3.93 Million USD | -54.27% |
| 2020 Q1 | -2.16 Million USD | -8.8% |
| 2020 FY | -9.08 Million USD | -25.54% |
| 2020 Q4 | -2.62 Million USD | -8.78% |
| 2020 Q3 | -2.41 Million USD | -28.18% |
| 2020 Q2 | -1.88 Million USD | 12.9% |
| 2019 Q1 | -1.91 Million USD | -115.45% |
| 2019 Q3 | -1.79 Million USD | -15.92% |
| 2019 FY | -7.24 Million USD | -199.94% |
| 2019 Q4 | -1.98 Million USD | -11.0% |
| 2019 Q2 | -1.54 Million USD | 19.36% |
| 2018 Q2 | -1.89 Million USD | -24.88% |
| 2018 FY | 7.24 Million USD | 237.54% |
| 2018 Q1 | -1.51 Million USD | 1.43% |
| 2018 Q4 | 12.4 Million USD | 807.59% |
| 2018 Q3 | -1.75 Million USD | 7.35% |
| 2017 FY | -5.26 Million USD | 45.33% |
| 2017 Q1 | -1.23 Million USD | -111.27% |
| 2017 Q2 | -1.26 Million USD | -2.35% |
| 2017 Q3 | -1.23 Million USD | 2.14% |
| 2017 Q4 | -1.53 Million USD | -24.45% |
| 2016 Q2 | -8.88 Million USD | 9.48% |
| 2016 Q1 | -9.81 Million USD | -15.46% |
| 2016 FY | -9.63 Million USD | 73.76% |
| 2016 Q4 | 10.94 Million USD | 682.1% |
| 2016 Q3 | -1.87 Million USD | 78.84% |
| 2015 FY | -36.72 Million USD | -18.8% |
| 2015 Q2 | -9.27 Million USD | -3.48% |
| 2015 Q1 | -8.96 Million USD | 7.9% |
| 2015 Q3 | -9.98 Million USD | -7.71% |
| 2015 Q4 | -8.5 Million USD | 14.9% |
| 2014 Q4 | -9.72 Million USD | -49.29% |
| 2014 Q1 | -6.89 Million USD | 27.15% |
| 2014 Q3 | -6.51 Million USD | 19.58% |
| 2014 Q2 | -8.1 Million USD | -17.45% |
| 2014 FY | -30.91 Million USD | -8.06% |
| 2013 FY | -28.6 Million USD | -26.88% |
| 2013 Q2 | -6.22 Million USD | 0.57% |
| 2013 Q4 | -9.47 Million USD | -42.29% |
| 2013 Q3 | -6.65 Million USD | -6.99% |
| 2013 Q1 | -6.25 Million USD | -192.11% |
| 2012 Q2 | 5.35 Million USD | 0.45% |
| 2012 FY | -22.54 Million USD | 16.91% |
| 2012 Q4 | 6.79 Million USD | 33.79% |
| 2012 Q1 | 5.32 Million USD | 180.33% |
| 2012 Q3 | 5.07 Million USD | -5.1% |
| 2011 FY | -27.13 Million USD | -192.42% |
| 2011 Q1 | 7.5 Million USD | -2.56% |
| 2011 Q2 | 7.09 Million USD | -5.58% |
| 2011 Q3 | 6.16 Million USD | -13.07% |
| 2011 Q4 | -6.62 Million USD | -207.58% |
| 2010 Q2 | 7.05 Million USD | -7.23% |
| 2010 Q3 | 7 Million USD | -0.72% |
| 2010 Q1 | 7.6 Million USD | -5.94% |
| 2010 Q4 | 7.7 Million USD | 10.07% |
| 2010 FY | 29.35 Million USD | -0.06% |
| 2009 Q3 | 6.98 Million USD | -5.52% |
| 2009 FY | 29.37 Million USD | 9.87% |
| 2009 Q1 | 6.92 Million USD | -2.45% |
| 2009 Q4 | 8.08 Million USD | 15.72% |
| 2009 Q2 | 7.39 Million USD | 6.75% |
| 2008 Q4 | 7.09 Million USD | 21.44% |
| 2008 Q3 | 5.84 Million USD | -15.28% |
| 2008 Q2 | 6.89 Million USD | 0.03% |
| 2008 Q1 | 6.89 Million USD | -17.13% |
| 2008 FY | 26.73 Million USD | -6.48% |
| 2007 Q2 | 6.03 Million USD | 192.82% |
| 2007 Q1 | -6.49 Million USD | -198.92% |
| 2007 Q3 | 7.73 Million USD | 28.22% |
| 2007 Q4 | 8.32 Million USD | 7.59% |
| 2007 FY | 28.59 Million USD | 33.79% |
| 2006 FY | 21.37 Million USD | 30.4% |
| 2006 Q1 | 4.48 Million USD | -2.57% |
| 2006 Q4 | 6.57 Million USD | 18.12% |
| 2006 Q3 | 5.56 Million USD | 17.0% |
| 2006 Q2 | 4.75 Million USD | 6.04% |
| 2005 FY | 16.38 Million USD | 6.42% |
| 2005 Q4 | 4.6 Million USD | 212.47% |
| 2005 Q3 | -4.09 Million USD | -200.19% |
| 2005 Q2 | 4.08 Million USD | 13.14% |
| 2005 Q1 | 3.6 Million USD | -28.27% |
| 2004 FY | 15.39 Million USD | 26.79% |
| 2004 Q2 | 3.27 Million USD | 18.38% |
| 2004 Q3 | -4.32 Million USD | -231.78% |
| 2004 Q4 | 5.03 Million USD | 216.48% |
| 2004 Q1 | 2.76 Million USD | -41.02% |
| 2003 Q1 | -2.34 Million USD | -235.9% |
| 2003 Q4 | 4.69 Million USD | 94.15% |
| 2003 Q3 | 2.41 Million USD | 190.16% |
| 2003 FY | 12.14 Million USD | 18.96% |
| 2003 Q2 | -2.68 Million USD | -14.15% |
| 2002 Q2 | 3.04 Million USD | 9.97% |
| 2002 Q4 | 1.72 Million USD | -35.37% |
| 2002 Q1 | 2.76 Million USD | -21.96% |
| 2002 FY | 10.21 Million USD | -11.88% |
| 2002 Q3 | 2.67 Million USD | -12.02% |
| 2001 Q1 | 2.54 Million USD | -28.4% |
| 2001 Q4 | 3.54 Million USD | 92.35% |
| 2001 FY | 11.58 Million USD | 25.04% |
| 2001 Q3 | 1.84 Million USD | -49.66% |
| 2001 Q2 | 3.65 Million USD | 44.01% |
| 2000 Q2 | -1.93 Million USD | -207.83% |
| 2000 Q3 | 1.97 Million USD | 202.01% |
| 2000 Q4 | 3.54 Million USD | 79.4% |
| 2000 FY | 9.26 Million USD | 193.69% |
| 2000 Q1 | 1.79 Million USD | 121.96% |
| 1999 Q3 | 6.6 Million USD | 430.0% |
| 1999 FY | -9.88 Million USD | -173.26% |
| 1999 Q1 | 2.1 Million USD | -12.5% |
| 1999 Q2 | -2 Million USD | -195.24% |
| 1999 Q4 | 810.37 Thousand USD | -87.72% |
| 1998 FY | 13.5 Million USD | 195.07% |
| 1998 Q4 | 2.4 Million USD | -22.58% |
| 1998 Q3 | 3.1 Million USD | 172.09% |
| 1998 Q2 | -4.3 Million USD | -13.16% |
| 1998 Q1 | -3.8 Million USD | -195.0% |
| 1997 FY | -14.2 Million USD | -190.45% |
| 1997 Q4 | 4 Million USD | 132.0% |
| 1997 Q3 | -12.5 Million USD | -1350.0% |
| 1997 Q2 | 1 Million USD | -78.26% |
| 1997 Q1 | 4.6 Million USD | -2.13% |
| 1996 FY | 15.7 Million USD | 109.33% |
| 1996 Q3 | 4 Million USD | 14.29% |
| 1996 Q2 | 3.5 Million USD | 2.94% |
| 1996 Q1 | 3.4 Million USD | 3.03% |
| 1996 Q4 | 4.7 Million USD | 17.5% |
| 1995 Q2 | 3.2 Million USD | 77.78% |
| 1995 FY | 7.5 Million USD | -55.62% |
| 1995 Q1 | 1.8 Million USD | -60.87% |
| 1995 Q4 | 3.3 Million USD | 22.22% |
| 1995 Q3 | 2.7 Million USD | -15.63% |
| 1994 Q2 | 4.5 Million USD | 60.71% |
| 1994 FY | 16.9 Million USD | 38.52% |
| 1994 Q1 | 2.8 Million USD | 121.37% |
| 1994 Q4 | 4.6 Million USD | -2.13% |
| 1994 Q3 | 4.7 Million USD | 4.44% |
| 1993 Q2 | 3.7 Million USD | 5.71% |
| 1993 Q3 | 200 Thousand USD | -94.59% |
| 1993 Q4 | -13.1 Million USD | -6650.0% |
| 1993 FY | 12.2 Million USD | 25.77% |
| 1993 Q1 | 3.5 Million USD | 132.71% |
| 1992 Q1 | 200 Thousand USD | 102.99% |
| 1992 FY | 9.7 Million USD | 51.56% |
| 1992 Q3 | 400 Thousand USD | 0.0% |
| 1992 Q2 | 400 Thousand USD | 100.0% |
| 1992 Q4 | -10.7 Million USD | -2775.0% |
| 1991 FY | 6.4 Million USD | 0.0% |
| 1991 Q2 | 100 Thousand USD | 0.0% |
| 1991 Q1 | 100 Thousand USD | 0.0% |
| 1991 Q4 | -6.7 Million USD | -6800.0% |
| 1991 Q3 | 100 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -57.66 Million USD | 82.911% |
| AngioDynamics, Inc. | -97.71 Million USD | 89.915% |
| AtriCure, Inc. | -26.68 Million USD | 63.066% |
| Avinger, Inc. | -16.63 Million USD | 40.757% |
| Azenta, Inc. | -73.12 Million USD | 86.523% |
| BioLife Solutions, Inc. | -70.82 Million USD | 86.085% |
| The Cooper Companies, Inc. | 533.1 Million USD | 101.849% |
| Daxor Corporation | -177.07 Thousand USD | -5465.438% |
| Ekso Bionics Holdings, Inc. | -15.11 Million USD | 34.787% |
| Femasys Inc. | -14.5 Million USD | 32.074% |
| GlucoTrack, Inc. | -7.1 Million USD | -38.725% |
| Harvard Bioscience, Inc. | 1.89 Million USD | 620.327% |
| Hologic, Inc. | 882.6 Million USD | 101.117% |
| ICU Medical, Inc. | 22.82 Million USD | 143.176% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 100.558% |
| KORU Medical Systems, Inc. | -10.26 Million USD | 4.041% |
| LeMaitre Vascular, Inc. | 37.08 Million USD | 126.576% |
| Innovative Eyewear, Inc. | -6.9 Million USD | -42.815% |
| Innovative Eyewear, Inc. | -6.9 Million USD | -42.815% |
| Masimo Corporation | 136.5 Million USD | 107.22% |
| Meihua International Medical Technologies Co., Ltd. | 14.67 Million USD | 167.155% |
| Merit Medical Systems, Inc. | 123.94 Million USD | 107.951% |
| Nephros, Inc. | -1.59 Million USD | -518.644% |
| NovoCure Limited | -232.87 Million USD | 95.768% |
| NEXGEL, Inc. | -3.47 Million USD | -183.434% |
| NEXGEL, Inc. | -3.47 Million USD | -183.434% |
| Singular Genomics Systems, Inc. | -102.8 Million USD | 90.414% |
| OraSure Technologies, Inc. | 54.07 Million USD | 118.223% |
| Pro-Dex, Inc. | 7.17 Million USD | 237.39% |
| Pulse Biosciences, Inc. | -43.57 Million USD | 77.383% |
| Predictive Oncology Inc. | -13.92 Million USD | 29.209% |
| Precision Optics Corporation, Inc. | -2.72 Million USD | -261.74% |
| QuidelOrtho Corporation | 139.1 Million USD | 107.085% |
| Repligen Corporation | 54.57 Million USD | 118.057% |
| Sanara MedTech Inc. | -4.21 Million USD | -133.799% |
| STAAR Surgical Company | 28.09 Million USD | 135.075% |
| Sharps Technology, Inc. | -10.12 Million USD | 2.683% |
| Utah Medical Products, Inc. | 16.77 Million USD | 158.741% |
| DENTSPLY SIRONA Inc. | -85 Million USD | 88.406% |
| Jin Medical International Ltd. | 2.86 Million USD | 443.708% |